+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Hrvatski Telekom dd (HT) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 37 Pages
  • July 2026
  • GlobalData
  • ID: 4433258
Hrvatski Telekom dd (HT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Hrvatski Telekom dd (Hrvatski Telekom), a subsidiary of Deutsche Telekom Europe BV, is a telecommunications services provider that offers fixed line, mobile services, wholesale, internet and data services, IoT services and international communications. The company offers services such as fixed telephone lines, internet protocol television (IPTV), global system for mobile communications (GSM) and universal mobile telecommunications system (UMTS) mobile networks, and data transfer solutions. It also offers support and cross-segment management functions including treasury, procurement, legal, technology, accounting and other central functions. The company caters to diverse customer base, including residential users, small and medium-sized businesses, corporate clients, and the public sector. Hrvatski Telekom is headquartered in Zagreb, Croatia.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Zhejiang Medicine Co Ltd - Key Facts
  • Zhejiang Medicine Co Ltd - Key Employees
  • Zhejiang Medicine Co Ltd - Key Employee Biographies
  • Zhejiang Medicine Co Ltd - Major Products and Services
  • Zhejiang Medicine Co Ltd - History
  • Zhejiang Medicine Co Ltd - Company Statement
  • Zhejiang Medicine Co Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Zhejiang Medicine Co Ltd - Business Description
  • Product Category: Anti-infective Medicines
  • Performance
  • Product Category: Hormone Medicines
  • Performance
  • Product Category: Hypoglycemic (Blood Sugar Lowering) Medicines
  • Performance
  • Product Category: Nutritional Supplement Products
  • Performance
  • Product Category: Other Business
  • Performance
  • Product Category: Others
  • Performance
  • Product Category: Pharmaceutical Commercial Distribution
  • Performance
  • Product Category: Vitamins and Vitamin Derivatives Series
  • Performance
  • Geographical Segment: Domestic Sales
  • Performance
  • Geographical Segment: Others
  • Performance
  • Geographical Segment: Overseas Sales
  • Performance
  • R&D Overview
  • Zhejiang Medicine Co Ltd - Corporate Strategy
  • Zhejiang Medicine Co Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Zhejiang Medicine Co Ltd - Strengths
  • Zhejiang Medicine Co Ltd - Weaknesses
  • Zhejiang Medicine Co Ltd - Opportunities
  • Zhejiang Medicine Co Ltd - Threats
  • Zhejiang Medicine Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Zhejiang Medicine Co Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 16, 2025: Shandong Pharmaceutical Industry Association Leads a Delegation of Key Enterprises to Visit
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Zhejiang Medicine Co Ltd, Key Facts
  • Zhejiang Medicine Co Ltd, Key Employees
  • Zhejiang Medicine Co Ltd, Key Employee Biographies
  • Zhejiang Medicine Co Ltd, Major Products and Services
  • Zhejiang Medicine Co Ltd, History
  • Zhejiang Medicine Co Ltd, Subsidiaries
  • Zhejiang Medicine Co Ltd, Key Competitors
  • Zhejiang Medicine Co Ltd, Ratios based on current share price
  • Zhejiang Medicine Co Ltd, Annual Ratios
  • Zhejiang Medicine Co Ltd, Interim Ratios
  • Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • Zhejiang Medicine Co Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Zhejiang Medicine Co Ltd, Performance Chart (2021 - 2025)
  • Zhejiang Medicine Co Ltd, Ratio Charts
  • Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • Zhejiang Medicine Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026